浩澤淨水(02014.HK)附屬獲投資者注資2,500萬人幣
浩澤淨水(02014.HK)公布,公司全資附屬上海浩澤淨水、間接非全資附屬佛山樂普達、投資者共青城樂匯投資中心,及佛山樂普達股東彭東琨訂立注資協議。投資者同意向佛山樂普達作出現金投資2,500萬元人民幣(下同),其中238萬元用作佛山樂普達的註冊資本及2,261.9萬元用作佛山樂普達的資本儲備。
待注資完成後,上海浩澤淨水、彭東琨及投資者於佛山樂普達所擁有的股權比例將分別約為47.2%、45.4%及7.4%。
目前,佛山樂普達由上海浩澤淨水及彭東琨分別持有51%及49%。待注資完成後,上海浩澤淨水於佛山樂普達持有的股權將由51%攤薄至約47.2%。(ek/w)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.